within Pharmacolibrary.Drugs.ATC.C;

model C04AX32_1
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.3,
    Cl             = 30 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 40 / 1000000,
    adminCount     = 1,
    Vd             = 0.04,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.008333333333333333,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Fasudil is a selective Rho-kinase inhibitor primarily used in the treatment of cerebral vasospasm following subarachnoid hemorrhage and has been investigated for use in pulmonary hypertension and other vascular conditions. It is approved in Japan but not widely approved elsewhere.</p><h4>Pharmacokinetics</h4><p>Parameters for a typical oral administration based on estimation, as oral data in humans are scarce.</p><h4>References</h4><ol><li><p>Wolff, AW, et al., &amp; Lingor, P (2024). SAFE-ROCK: A Phase I Trial of an Oral Application of the ROCK Inhibitor Fasudil to Assess Bioavailability, Safety, and Tolerability in Healthy Participants. <i>CNS drugs</i> 38(4) 291–302. DOI:<a href=&quot;https://doi.org/10.1007/s40263-024-01070-7&quot;>10.1007/s40263-024-01070-7</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38416402/&quot;>https://pubmed.ncbi.nlm.nih.gov/38416402</a></p></li><li><p>Takase, S, et al., &amp; Yamada, K (2022). Antipsychotic-like effects of fasudil, a Rho-kinase inhibitor, in a pharmacologic animal model of schizophrenia. <i>European journal of pharmacology</i> 931 175207–None. DOI:<a href=&quot;https://doi.org/10.1016/j.ejphar.2022.175207&quot;>10.1016/j.ejphar.2022.175207</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35987254/&quot;>https://pubmed.ncbi.nlm.nih.gov/35987254</a></p></li><li><p>Wu, Y, et al., &amp; Zhong, G (2023). Pharmacokinetic and safety profile of PT109B, a novel multi-targeted compound against Alzheimer&#x27;s disease. <i>European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences</i> 188 106532–None. DOI:<a href=&quot;https://doi.org/10.1016/j.ejps.2023.106532&quot;>10.1016/j.ejps.2023.106532</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37479046/&quot;>https://pubmed.ncbi.nlm.nih.gov/37479046</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C04AX32_1;
